<DOC>
	<DOCNO>NCT02577913</DOCNO>
	<brief_summary>This study compare risk short- long-term use FC Patch Low levonorgestrel-containing combine oral contraceptive ( COC-LNG ) study population representative actual user individual preparation . FC Patch Low transdermal contraceptive patch apply week three consecutive week follow break one week ( 21/7 ) . One patch contain 2.1mg gestodene 0.55mg ethinyl estradiol , equivalent release 0.06mg gestodene 0.013mg ethinyl estradiol per 24 hour .</brief_summary>
	<brief_title>European Active Surveillance Study Comparing Regimens Administration Combined Hormonal Contraception</brief_title>
	<detailed_description>FC Patch Low transdermal contraceptive patch apply week three consecutive week follow break one week ( 21/7 ) . One patch contain 2.1mg gestodene 0.55mg ethinyl estradiol , equivalent release 0.06mg gestodene 0.013mg ethinyl estradiol per 24 hour . The relevant adverse clinical outcome link use COCs venous thromboembolism ( VTE ) . Data randomize clinical trial show serious health concern FC Patch Low . However , statistical power detect rare adverse event limited study . EURAS-CORA large , prospective , control , long-term active surveillance study investigate safety FC Patch Low regard outcomes interest . This study follow European Active Surveillance ( EURAS ) design methodology modification due country- product-specific characteristic . The outcomes interest validate via attend physician . A multi-faceted follow-up procedure ensure low loss follow-up rate . This study involve woman Europe follow 2 year . Data analysis include multivariable technique Cox regression .</detailed_description>
	<mesh_term>Levonorgestrel</mesh_term>
	<criteria>There specific medical inclusion/exclusion criterion age restriction First ever user combine hormonal contraceptive `` starter '' User restarts combine hormonal contraceptive leat two month break `` restarter '' Women willing participate active surveillance study Women understand major aspect study</criteria>
	<gender>Female</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>contraception</keyword>
	<keyword>contraceptive patch</keyword>
	<keyword>Levonorgestrel</keyword>
	<keyword>gestodene</keyword>
	<keyword>safety</keyword>
</DOC>